# CR-CHOP+X in Previously Untreated DEL

> **NCT06701357** · PHASE2 · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 49 (estimated)

## Conditions studied

- DLBCL

## Interventions

- **DRUG:** CR-CHOP+PD1 inhibitor
- **DRUG:** CR-CHOP + Orelabrutinib
- **DRUG:** CR-CHOP + decitabine

## Key facts

- **NCT ID:** NCT06701357
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2026-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06701357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06701357, "CR-CHOP+X in Previously Untreated DEL". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06701357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*